The Outcomes of PBMV in Pregnancy, and When is the Best Time?
- PMID: 36687312
- PMCID: PMC9849788
- DOI: 10.2147/VHRM.S388754
The Outcomes of PBMV in Pregnancy, and When is the Best Time?
Abstract
Background: Percutaneous balloon mitral valvuloplasty (PBMV) is considered the most suitable option for managing symptomatic severe mitral valve stenosis (MS) during pregnancy with favorable anatomy. We do not know the best time to perform PBMV during pregnancy to achieve the best maternal and fetal outcomes. Therefore, we conducted this study to clarify the best procedure timing.
Methods: This prospective, observational, single-center study involved 44 pregnant patients suffering from symptomatic MS who underwent PBMV from May 2017 to May 2020. A detailed history is taken, full clinical examination, laboratory assessment, 2 D echocardiography, and follow-up during the hospital stay and monthly until labor.
Results: We found that the mean mitral valve area (MVA) had significantly increased from 1.12 ± 0.24 to 2.09 ± 0.46 cm2 (P < 0.001). The mean pressure gradient across the mitral valve reduced from 17.22 ± 5.55 to 8.94 ± 3.75 mmHg (P < 0.001). The procedures were successful in 91% of the patients. Regarding obstetric outcomes, the incidence of preterm labor, fetal death, and composite adverse outcomes was significantly lower in patients who had the procedure during the second trimester than those who had the procedure during the third trimester. All preterm deliveries and intrauterine fetal deaths occurred at least 21 days after PBMV. The patients showed a statistically significant improvement in NYHA functional classification.
Conclusion: We can conclude that PBMV performed in pregnant patients is an effective and safe treatment modality, and we observed better obstetric outcomes achieved with early intervention during the second trimester.
Keywords: PBMV; mitral stenosis; obstetric outcomes; pregnancy; rheumatic heart disease.
© 2023 Hussein et al.
Conflict of interest statement
The authors report no conflicts of interest for this work.
Figures
Similar articles
-
Incidence and predictors of adverse outcomes in patients with rheumatic mitral stenosis following percutaneous balloon mitral valvuloplasty: a study from a tertiary center in Thailand.BMC Cardiovasc Disord. 2024 Jul 29;24(1):391. doi: 10.1186/s12872-024-04067-8. BMC Cardiovasc Disord. 2024. PMID: 39069638 Free PMC article.
-
Percutaneous Balloon Mitral Valvuloplasty During Antenatal Care and Apgar Score: The ANC-Valve Study.J Invasive Cardiol. 2020 Nov;32(11):427-432. doi: 10.25270/jic/20.00101. J Invasive Cardiol. 2020. PMID: 33130593
-
Feasibility and effectiveness of percutaneous balloon mitral valvuloplasty under echocardiographic guidance only.Echocardiography. 2018 Oct;35(10):1507-1511. doi: 10.1111/echo.14055. Epub 2018 Jun 19. Echocardiography. 2018. PMID: 29920758
-
Percutaneous balloon mitral valvotomy during pregnancy: A systematic review and meta-analysis.Acta Obstet Gynecol Scand. 2021 Apr;100(4):666-675. doi: 10.1111/aogs.14029. Epub 2020 Nov 2. Acta Obstet Gynecol Scand. 2021. PMID: 33070306
-
In-hospital and Readmission Outcomes With Percutaneous Balloon Mitral Valvuloplasty.Curr Probl Cardiol. 2022 Dec;47(12):101367. doi: 10.1016/j.cpcardiol.2022.101367. Epub 2022 Aug 23. Curr Probl Cardiol. 2022. PMID: 36007617 Review.
References
-
- Block PC, Palacios IF. Pulmonary vascular dynamics after percutaneous mitral valvotomy. J Thorac Cardiovasc Surg. 1988;96:39–43. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources